The study reported a comprehensive anticancer mechanism of eugenol against cancer cell lines, involving the promotion of translocation of the pro-apoptotic gene Bax, a decrease in the anti-apoptotic gene Bcl-2, the release of cytochrome c, and the activation of caspase-9 and caspase-3. Here, CYCS is linked to cancer.